Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2018 Filed Jan 5, 2018 21:24 UTC |
Hughes Thomas E.Director
|
GrantStock Option (right to buy) · Derivative | 3,426 | $0.00 Strike: $9.72 | $0.00 |
DisclosureSEC source: 0001209191-18-002465 · doc4.xml · derivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,426 Underlying: Common Stock · 3,426 shares Expires 2028-01-02 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in four equal quarterly installments beginning on January 1, 2018 through December 31, 2018, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant. Read SEC document |
| December 20, 2017 Filed Dec 22, 2017 23:08 UTC |
Hughes Thomas E.Director
|
SaleCommon Stock | 12,000 | $8.00 | $96,000.00 |
DisclosureSEC source: 0001209191-17-067133 · doc4.xml · nonDerivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,827 F1 · balance_after: Includes 765 shares previously reported as holdings of the Reporting Person granted pursuant to a restricted stock award under the Issuer's 2016 Equity Incentive Plan. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 17:22 UTC |
Creecy John WDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042572 · doc4.xml · derivative · entry 1 Creecy John W · CIK 0001689143 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F1 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 21:19 UTC |
Booth BruceDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042569 · doc4.xml · derivative · entry 1 Booth Bruce · CIK 0001451612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F1 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. F2 · ownership.direct: This option was granted to Bruce Booth, Ph.D., a director of the Issuer. The proceeds of any sale of shares of common stock issued to Dr. Booth upon exercise of this option will be transferred to Atlas Venture Advisors, Inc. and therefore Dr. Booth disclaims beneficial ownership of such shares, which belongs to Atlas Venture Advisors, Inc. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 17:23 UTC |
TURNER JOSEPH LDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042573 · doc4.xml · derivative · entry 1 TURNER JOSEPH L · CIK 0001266129 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F1 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 21:24 UTC |
KOCH KEVINDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042574 · doc4.xml · derivative · entry 1 KOCH KEVIN · CIK 0001185829 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F1 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 17:24 UTC |
LEFKOFF KYLEDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042575 · doc4.xml · derivative · entry 1 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F1 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 28, 2017 Filed Jun 30, 2017 21:21 UTC |
Hughes Thomas E.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001209191-17-042571 · doc4.xml · derivative · entry 2 Hughes Thomas E. · CIK 0001611048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-06-27 F2 · derivative.exercise_date: Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 19:07 UTC |
Levy Adam ScottChief Business Officer
|
PurchaseCommon Stock | 200 | $7.55 | $1,510.00 |
DisclosureSEC source: 0001209191-17-041768 · doc4.xml · nonDerivative · entry 1 Levy Adam Scott · CIK 0001693134 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.50 to $7.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 21:17 UTC |
Booth BruceDirector
|
GrantStock Option (right to buy) · Derivative | 6,844 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-17-023171 · doc4.xml · derivative · entry 1 Booth Bruce · CIK 0001451612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,844 Underlying: Common Stock · 6,844 shares Expires 2027-03-23 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant. F2 · ownership.direct: This option was granted to Bruce Booth, a director of the Issuer. The proceeds of any sale of shares of common stock issued to Mr. Booth upon exercise of this option will be transferred to Atlas Venture Advisors, Inc. and therefore Mr. Booth disclaims beneficial ownership of such shares, which belongs to Atlas Venture Advisors, Inc. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 21:15 UTC |
Hughes Thomas E.Director
|
GrantStock Option (right to buy) · Derivative | 1,191 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-17-023165 · doc4.xml · derivative · entry 2 Hughes Thomas E. · CIK 0001611048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Underlying: Common Stock · 1,191 shares Expires 2027-03-23 F2 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Plan. The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 21:15 UTC |
Hughes Thomas E.Director
|
GrantCommon Stock | 778 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-023165 · doc4.xml · nonDerivative · entry 1 Hughes Thomas E. · CIK 0001611048 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,840 F1 · shares: Grant to the Reporting Person of a restricted stock award under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 18:37 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 3,300 | $14.31 | $47,228.94 |
DisclosureSEC source: 0001209191-17-020291 · doc4.xml · nonDerivative · entry 2 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 463,473 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.96 to $14.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 09, 2017 Filed Mar 13, 2017 18:37 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 2,500 | $14.38 | $35,961.50 |
DisclosureSEC source: 0001209191-17-020291 · doc4.xml · nonDerivative · entry 1 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 466,773 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 08, 2017 Filed Mar 8, 2017 17:12 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 5,000 | $14.70 | $73,514.00 |
DisclosureSEC source: 0001209191-17-019319 · doc4.xml · nonDerivative · entry 3 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 469,273 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $15.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:12 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 608 | $16.24 | $9,873.80 |
DisclosureSEC source: 0001209191-17-019319 · doc4.xml · nonDerivative · entry 2 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 474,273 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.21 to $16.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 17:12 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 9,392 | $15.71 | $147,589.64 |
DisclosureSEC source: 0001209191-17-019319 · doc4.xml · nonDerivative · entry 1 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 474,881 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $16.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 28, 2017 Filed Feb 28, 2017 18:52 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 2,258 | $13.54 | $30,580.09 |
DisclosureSEC source: 0001209191-17-015457 · doc4.xml · nonDerivative · entry 3 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 484,273 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $13.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 18:52 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 1,500 | $13.79 | $20,686.50 |
DisclosureSEC source: 0001209191-17-015457 · doc4.xml · nonDerivative · entry 2 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 486,531 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.75 to $13.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 18:52 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 6,500 | $14.04 | $91,252.20 |
DisclosureSEC source: 0001209191-17-015457 · doc4.xml · nonDerivative · entry 1 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 488,031 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 23, 2017 Filed Feb 24, 2017 19:07 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 1,800 | $13.65 | $24,565.86 |
DisclosureSEC source: 0001209191-17-014537 · doc4.xml · nonDerivative · entry 2 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 494,531 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.50 to $14.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 19:07 UTC |
LEFKOFF KYLEDirector
|
SaleCommon Stock | 4,102 | $14.36 | $58,885.85 |
DisclosureSEC source: 0001209191-17-014537 · doc4.xml · nonDerivative · entry 1 LEFKOFF KYLE · CIK 0001191818 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 496,331 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.28 to $14.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. F2 · ownership.nature: All of the shares are held by Boulder Ventures VI, L.P. ("BV VI LP"). BV Partners VI, LLC ("BV VI LLC"), the general partner of BV VI LP may be deemed to indirectly beneficially own the shares. Kyle A. Lefkoff, Peter A. Roshko and Jonathan L. Perl are managing members of BV VI LLC, and each share voting and dispositive power over the shares held by BV VI LP. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein, if any. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 20:25 UTC |
Levy Adam ScottChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $11.01 | $0.00 |
DisclosureSEC source: 0001209191-17-011779 · doc4.xml · derivative · entry 1 Levy Adam Scott · CIK 0001693134 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2027-02-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 20:23 UTC |
Marshall William StuartDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $11.01 | $0.00 |
DisclosureSEC source: 0001209191-17-011777 · doc4.xml · derivative · entry 1 Marshall William Stuart · CIK 0001693127 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-02-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 01:28 UTC |
Leverone Jason A.CFO, Treasurer & Secretary
|
GrantStock Option (right to buy) · Derivative | 77,500 | $0.00 Strike: $11.01 | $0.00 |
DisclosureSEC source: 0001209191-17-011783 · doc4.xml · derivative · entry 1 Leverone Jason A. · CIK 0001692747 · CFO, Treasurer & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,500 Underlying: Common Stock · 77,500 shares Expires 2027-02-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 01:26 UTC |
RUBIN PAUL DEVP, Research & Development
|
GrantStock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $11.01 | $0.00 |
DisclosureSEC source: 0001209191-17-011781 · doc4.xml · derivative · entry 1 RUBIN PAUL D · CIK 0001210905 · EVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2027-02-15 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in 48 equal monthly installments beginning on February 16, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The shares underlying the option are subject to accelerated vesting upon the occurrence of specified events including a change of control of the Issuer and the Reporting Person's termination. The option expires ten years after the date of grant. Read SEC document |
| February 13, 2017 Filed Feb 13, 2017 18:05 UTC |
LEBOW BENNETT SDirector · 10% owner
|
Exercise / conversionUnsecured Demand Promissory Note · Derivative | Not disclosed | $0.00 Strike: $5.39 | $1,045,000.00 |
DisclosureSEC source: 0000899243-17-003819 · doc4.xml · derivative · entry 4 LEBOW BENNETT S · CIK 0001005790 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 279,067 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.expiration_date: At any time on or after June 30, 2015, the Note was payable upon demand of the reporting person. F7 · derivative.underlying_shares: See footnote (6). The Outstanding Balance on February 13, 2017 was $1,355,365, consisting of an unpaid principal balance of $1,045,000 and accrued interest of $310,365. The Premium was $149,090.15. Read SEC document |
| February 13, 2017 Filed Feb 13, 2017 18:05 UTC |
LEBOW BENNETT SDirector · 10% owner
|
GrantUnsecured Demand Promissory Note · Derivative | Not disclosed | $0.00 Strike: $5.39 | $1,045,000.00 |
DisclosureSEC source: 0000899243-17-003819 · doc4.xml · derivative · entry 3 LEBOW BENNETT S · CIK 0001005790 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · Not disclosed shares Expires not disclosed F4 · kind: On October 31, 2016, the issuer and the reporting person agreed, subject to the approval of the issuer's stockholders which was given on February 10, 2017, to amend the Note to provide for automatic conversion of the unpaid principal balance and all accrued interest on the Note (the "Outstanding Balance"), plus a premium of 11% on the Outstanding Balance (the "Premium"), into Common Stock, immediately prior to the effective time of the Merger. The Merger closed on February 13, 2017. See "Remarks". F4 · derivative.exercise_date: On October 31, 2016, the issuer and the reporting person agreed, subject to the approval of the issuer's stockholders which was given on February 10, 2017, to amend the Note to provide for automatic conversion of the unpaid principal balance and all accrued interest on the Note (the "Outstanding Balance"), plus a premium of 11% on the Outstanding Balance (the "Premium"), into Common Stock, immediately prior to the effective time of the Merger. The Merger closed on February 13, 2017. See "Remarks". F5 · derivative.expiration_date: At any time on or after June 30, 2015, the Note was payable upon demand of the reporting person. F6 · derivative.underlying_shares: The number of shares of Common Stock into which the Note was made convertible is determined by dividing (i) the sum of the Outstanding Balance plus the Premium by (ii) the closing market price of the Common Stock on the Nasdaq Capital Market on October 31, 2016 of $5.39, as adjusted to reflect the Reverse Split (the "Conversion Price"). Read SEC document |
| February 13, 2017 Filed Feb 13, 2017 18:05 UTC |
LEBOW BENNETT SDirector · 10% owner
|
Exercise / conversionCommon Stock | 279,067 | $5.39 | $1,504,171.13 |
DisclosureSEC source: 0000899243-17-003819 · doc4.xml · nonDerivative · entry 1 LEBOW BENNETT S · CIK 0001005790 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Immediately prior to the effective time of the Merger, that certain Unsecured Demand Promissory Note (the "Note"), dated March 6, 2015, as amended, issued by the issuer to the reporting person was converted into Common Stock. See footnote (4). F2 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the conversion price reported reflect the Reverse Split. F2 · price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the conversion price reported reflect the Reverse Split. F2 · balance_after: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the conversion price reported reflect the Reverse Split. Read SEC document |
| February 08, 2017 Filed Feb 8, 2017 20:50 UTC |
Gonyer David ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0000899243-17-003211 · doc4.xml · derivative · entry 2 Gonyer David A · CIK 0001578768 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F2 · derivative.exercise_date: The option initially vested and became exercisable in twelve equal monthly installments beginning on June 30, 2016 and ending on May 31, 2017. However, upon approval of the issuer's board of directors, vesting was accelerated and the option became fully vested. F1 · derivative.underlying_shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| February 08, 2017 Filed Feb 8, 2017 20:50 UTC |
Gonyer David ADirector
|
Exercise / conversionCommon Stock | 1,200 | $7.65 | $9,180.00 |
DisclosureSEC source: 0000899243-17-003211 · doc4.xml · nonDerivative · entry 1 Gonyer David A · CIK 0001578768 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · balance_after: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:08 UTC |
LEBOW BENNETT SDirector · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0000899243-17-003024 · doc4.xml · derivative · entry 3 LEBOW BENNETT S · CIK 0001005790 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F3 · derivative.exercise_date: The option initially vested and became exercisable in twelve equal monthly installments beginning on June 30, 2016 and ending on May 31, 2017. However, upon approval of the issuer's board of directors, vesting was accelerated and the option became fully vested. F1 · derivative.underlying_shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:08 UTC |
LEBOW BENNETT SDirector · 10% owner
|
Exercise / conversionCommon Stock | 1,200 | $7.65 | $9,180.00 |
DisclosureSEC source: 0000899243-17-003024 · doc4.xml · nonDerivative · entry 1 LEBOW BENNETT S · CIK 0001005790 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · balance_after: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:08 UTC |
Smith Robin LDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $7.65 | $0.00 |
DisclosureSEC source: 0000899243-17-003023 · doc4.xml · derivative · entry 2 Smith Robin L · CIK 0001365035 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2026-06-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F2 · derivative.exercise_date: The option initially vested and became exercisable in twelve equal monthly installments beginning on June 30, 2016 and ending on May 31, 2017. However, upon approval of the issuer's board of directors, vesting was accelerated and the option became fully vested. F1 · derivative.underlying_shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 21:08 UTC |
Smith Robin LDirector
|
Exercise / conversionCommon Stock | 1,200 | $7.65 | $9,180.00 |
DisclosureSEC source: 0000899243-17-003023 · doc4.xml · nonDerivative · entry 1 Smith Robin L · CIK 0001365035 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · price: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. F1 · balance_after: On November 4, 2016, the issuer effected a one-for-15 reverse split of its Common Stock (the "Reverse Split"), and the number of securities and/or the exercise price reported reflect the Reverse Split. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:37 UTC |
Riccitelli Samuel DDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148044 · doc4.xml · derivative · entry 3 Riccitelli Samuel D · CIK 0001414839 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The restricted stock units reported herein converted into common stock on a one-for-one basis. F1 · derivative.exercise_price: The restricted stock units reported herein converted into common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 28, 2016, the reporting person was granted 200,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full. F3 · derivative.expiration_date: On March 28, 2016, the reporting person was granted 200,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:37 UTC |
Riccitelli Samuel DDirector · President & CEO
|
Tax withholdingCommon Stock | 103,160 | $0.36 | $37,137.60 |
DisclosureSEC source: 0001209191-16-148044 · doc4.xml · nonDerivative · entry 2 Riccitelli Samuel D · CIK 0001414839 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 571,370 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 20:37 UTC |
Riccitelli Samuel DDirector · President & CEO
|
Exercise / conversionCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148044 · doc4.xml · nonDerivative · entry 1 Riccitelli Samuel D · CIK 0001414839 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units reported herein converted into common stock on a one-for-one basis. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · derivative · entry 6 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 28, 2016, the reporting person was granted 100,000 restricted stock units. In connection with the execution of the Merger Agreement, the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full. F4 · derivative.expiration_date: On March 28, 2016, the reporting person was granted 100,000 restricted stock units. In connection with the execution of the Merger Agreement, the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 46,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · derivative · entry 5 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units converted into common stock on a one-for-one basis. F3 · derivative.exercise_date: On August 4, 2014, the reporting person was granted 92,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of the remaining 46,000 restricted stock units in full. F3 · derivative.expiration_date: On August 4, 2014, the reporting person was granted 92,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of the remaining 46,000 restricted stock units in full. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Tax withholdingCommon Stock | 45,580 | $0.36 | $16,408.80 |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · nonDerivative · entry 4 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 106,447 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Exercise / conversionCommon Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · nonDerivative · entry 3 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 152,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units converted into common stock on a one-for-one basis. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Tax withholdingCommon Stock | 20,967 | $0.36 | $7,548.12 |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · nonDerivative · entry 2 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 52,027 F2 · shares: Shares withheld to satisfy tax withholding obligations. Read SEC document |
| October 31, 2016 Filed Nov 3, 2016 00:39 UTC |
FAVORITO TAMARA ACFO, Secretary, Treasurer
|
Exercise / conversionCommon Stock | 46,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148045 · doc4.xml · nonDerivative · entry 1 SEYMOUR TAMARA A · CIK 0001288232 · CFO, Secretary, Treasurer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 72,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units converted into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.